News - ARRIVO Bioventures

News

Product Development

Financial

Recognition

Product Development

May.21.2026

Arrivo Bio to Present Clinical Data on Forvisirvat at 2026 ASCP Annual Meeting

February.3.2026

Arrivo Bio Promotes Kelly Abernathy to Chief Operating Officer

November.19.2025

Arrivo Bio to Present and Meet with Investors at the 37th Annual Piper Sandler Healthcare Conference

November.12.2025

Arrivo Bio to Present Early Clinical Data on RABI-767 at the 2025 American Pancreatic Association Annual Meeting

August.14.2025

Arrivo BioVentures to Participate in Piper Sandler Virtual CNS Symposium

May.27.2025

Arrivo BioVentures to Present Phase 1 qEEG Data at 2025 ASCP Annual Meeting

Feb.26.2025

Arrivo BioVentures’ SIRT6 Activator Receives United States Adopted…

Jan.10.2025

Arrivo BioVentures Announces Positive Results from qEEG….jj

Oct.29.2024

Arrivo targets major depressive disorder in females after early….

Oct.10.2024

Arrivo BioVentures Begins Phase 1 Study of SP-624, the First….jj

Jul.15.2024

Arrivo Announces FDA Fast Track Designation for RABI-767 for….

Aril.16.2024

Arrivo Initiates Large Phase 2b Clinical Trial in Major Depressive….

Oct.19.2022

Morrisville Drugmaker Sees Promise in Depression Treatment…

Oct.17.2022

Arrivo BioVentures Announces SP-624 Demonstrated…

May.26.2022

Arrivo BioVentures Closes Enrollment in Large Phase 2 Clinical….

Dec.14.2021

Morrisville biotech emerges from stealth mode with 4 drugs….

Dec.10.2021

Arrivo BioVentures Emerges from Stealth Mode with 4 drugs in….

May.25.2016

Serial BioPharma Entrepreneurial Team Launches….

Financial

Nov.30.2023

How this Triangle drugmaker secured $45M amid brutal….

Nov.29.2023

ArrivoBio Raises $45M in Series B Financing to Advance Pipeline

Nov.29.2023

Arrivo bags $45M Series B to fund major depression late-stage….

Sep.02.2016

Solas BioVentures to Seek Up to $100M for Second Early-Stage…

May.26.2016

Term sheet – Venture Capital Deals rivo bags $45M Series B to fund

May.26.2016

Serial BioPharma Entrepreneurial Team launches drug….

May.26.2016

Fresh off raising $49M for Arrivo, biotech teammates ‘energized’

May.25.2016

Arrivo debuts with $49M to Seek Up to $100M for Secondary

May.25.2016

Arrivo BioVentures LLC says it raised $49 mln in equity financing

May.25.2016

How these Morrisville execs landed $49M from investors….

May.25.2016

Veteran biotech entrepreneurs launch new venture with….

May.25.2016

Biotech entrepreneurs grab $49M to bankroll a neuroscience startup

May.25.2016

New Arrivo: Triangle Pharma Wizards Put $49M to Work…….

May.25.2016

Serial BioPharma Entrepreneurial Team Launches Arrivo….

Recognition

Jan.03.2024

Psychiatry and Neuroscience Expert Dr. Joel Raskin Joins….

Dec.14.2021

Triangle biotech startup emerges with a bang – $49M and 4 drug….

Jan.03.2017

What You Need to Know About Arrivo Bioventures…. and the

Jan.03.2017

The Next Generation: Top 20 Life Science Startups to Watch….

May.25.2016

Serial BioPharma Entrepreneurial Team Launches Arrivo….

May.25.2016

Drug Developer Arrivo BioVentures Launches with $49M….